It is reported that sub-or low micromolar concentrations of NO-Aspirin inhibited the proliferation of tumorigenic lung cancer in vitro and in vivo via attenuation of EGFR and its downstream effectors [55]. The gene discussed is EGFR; the disease is lung carcinoma.